vs
Strive, Inc.(ASST)与Dianthus Therapeutics, Inc.(DNTH)财务数据对比。点击上方公司名可切换其他公司
Dianthus Therapeutics, Inc.的季度营收约是Strive, Inc.的1.1倍($284.0K vs $255.0K),Dianthus Therapeutics, Inc.净利率更高(-22687.3% vs -75406.7%,领先52719.3%),Strive, Inc.同比增速更快(-74.1% vs -78.6%),过去两年Strive, Inc.的营收复合增速更高(77.6% vs -44.6%)
斯特赖夫资产管理是一家2022年成立的美国投资管理机构,总部位于俄亥俄州哥伦布市,是斯特赖夫企业股份有限公司旗下子公司。该机构提供共同基金、交易所交易产品以及财富管理服务,是美国证监会注册的投资顾问。
Dianthus Therapeutics是一家临床阶段生物制药企业,专注开发罕见免疫与炎症疾病的新型靶向疗法,其抗体类候选管线聚焦解决重症患者未满足医疗需求,主要在北美开展临床研究与合作。
ASST vs DNTH — 直观对比
营收规模更大
DNTH
是对方的1.1倍
$255.0K
营收增速更快
ASST
高出4.5%
-78.6%
净利率更高
DNTH
高出52719.3%
-75406.7%
两年增速更快
ASST
近两年复合增速
-44.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $255.0K | $284.0K |
| 净利润 | $-192.3M | $-64.4M |
| 毛利率 | — | — |
| 营业利润率 | -17288.6% | -24486.3% |
| 净利率 | -75406.7% | -22687.3% |
| 营收同比 | -74.1% | -78.6% |
| 净利润同比 | -2726.9% | -126.6% |
| 每股收益(稀释后) | $-0.22 | $-1.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASST
DNTH
| Q4 25 | — | $284.0K | ||
| Q3 25 | $255.0K | $396.0K | ||
| Q2 25 | $173.3K | — | ||
| Q1 25 | $170.7K | $1.2M | ||
| Q4 24 | $212.8K | $1.3M | ||
| Q3 24 | $984.0K | $2.2M | ||
| Q2 24 | $93.0K | $1.9M | ||
| Q1 24 | $124.8K | $874.0K |
净利润
ASST
DNTH
| Q4 25 | — | $-64.4M | ||
| Q3 25 | $-192.3M | $-36.8M | ||
| Q2 25 | $-8.9M | — | ||
| Q1 25 | $-3.7M | $-29.5M | ||
| Q4 24 | $-4.1M | $-28.4M | ||
| Q3 24 | $-6.8M | $-25.2M | ||
| Q2 24 | $-5.9M | $-17.6M | ||
| Q1 24 | $-4.8M | $-13.7M |
营业利润率
ASST
DNTH
| Q4 25 | — | -24486.3% | ||
| Q3 25 | -17288.6% | -10173.7% | ||
| Q2 25 | -1553.9% | — | ||
| Q1 25 | -970.5% | -2852.7% | ||
| Q4 24 | -5889.5% | -2406.9% | ||
| Q3 24 | -712.4% | -1376.6% | ||
| Q2 24 | -1857.2% | -1191.8% | ||
| Q1 24 | -1110.9% | -2041.6% |
净利率
ASST
DNTH
| Q4 25 | — | -22687.3% | ||
| Q3 25 | -75406.7% | -9284.1% | ||
| Q2 25 | -5122.4% | — | ||
| Q1 25 | -2195.6% | -2537.5% | ||
| Q4 24 | -1935.5% | -2144.8% | ||
| Q3 24 | -691.3% | -1159.0% | ||
| Q2 24 | -6313.1% | -945.1% | ||
| Q1 24 | -3837.7% | -1573.0% |
每股收益(稀释后)
ASST
DNTH
| Q4 25 | — | $-1.53 | ||
| Q3 25 | $-0.22 | $-0.97 | ||
| Q2 25 | $-0.17 | — | ||
| Q1 25 | $-0.13 | $-0.82 | ||
| Q4 24 | $-5.62 | $-0.76 | ||
| Q3 24 | $-3.06 | $-0.74 | ||
| Q2 24 | $-0.58 | $-0.51 | ||
| Q1 24 | $-0.49 | $-0.54 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $109.1M | $404.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.4M | $493.4M |
| 总资产 | $792.6M | $530.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASST
DNTH
| Q4 25 | — | $404.3M | ||
| Q3 25 | $109.1M | $402.6M | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $4.2M | $263.2M | ||
| Q4 24 | $6.2M | $275.2M | ||
| Q3 24 | $2.1M | $281.1M | ||
| Q2 24 | $1.9M | $360.7M | ||
| Q1 24 | $1.9M | $377.0M |
股东权益
ASST
DNTH
| Q4 25 | — | $493.4M | ||
| Q3 25 | $779.4M | $546.5M | ||
| Q2 25 | $10.7M | — | ||
| Q1 25 | $19.6M | $328.6M | ||
| Q4 24 | $23.3M | $352.5M | ||
| Q3 24 | $27.5M | $337.9M | ||
| Q2 24 | $5.4M | $358.2M | ||
| Q1 24 | $11.3M | $372.7M |
总资产
ASST
DNTH
| Q4 25 | — | $530.9M | ||
| Q3 25 | $792.6M | $577.4M | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $5.0M | $348.6M | ||
| Q4 24 | $28.2M | $374.0M | ||
| Q3 24 | $2.6M | $354.2M | ||
| Q2 24 | $2.4M | $369.0M | ||
| Q1 24 | $2.1M | $382.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-14.0M | $-47.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.1M |
| 自由现金流率自由现金流/营收 | — | -16591.9% |
| 资本支出强度资本支出/营收 | 0.0% | 48.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-132.8M |
8季度趋势,按日历期对齐
经营现金流
ASST
DNTH
| Q4 25 | — | $-47.0M | ||
| Q3 25 | $-14.0M | $-30.6M | ||
| Q2 25 | $-1.7M | — | ||
| Q1 25 | $-1.6M | $-27.6M | ||
| Q4 24 | $-21.6M | $-27.4M | ||
| Q3 24 | $-13.2M | $-21.3M | ||
| Q2 24 | $-1.3M | $-14.5M | ||
| Q1 24 | $-1.0M | $-14.9M |
自由现金流
ASST
DNTH
| Q4 25 | — | $-47.1M | ||
| Q3 25 | — | $-30.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-27.7M | ||
| Q4 24 | $-21.6M | $-27.5M | ||
| Q3 24 | $-13.4M | $-21.3M | ||
| Q2 24 | $-1.3M | $-14.5M | ||
| Q1 24 | $-1.1M | $-15.0M |
自由现金流率
ASST
DNTH
| Q4 25 | — | -16591.9% | ||
| Q3 25 | — | -7717.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -2377.8% | ||
| Q4 24 | -10161.2% | -2072.0% | ||
| Q3 24 | -1360.3% | -980.3% | ||
| Q2 24 | -1379.4% | -780.7% | ||
| Q1 24 | -844.7% | -1713.2% |
资本支出强度
ASST
DNTH
| Q4 25 | — | 48.6% | ||
| Q3 25 | 0.0% | 1.3% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | 11.3% | 2.3% | ||
| Q3 24 | 18.8% | 1.2% | ||
| Q2 24 | 3.1% | 0.9% | ||
| Q1 24 | 9.5% | 3.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图